In one of the largest and most rigorous clinical investigations of psychedelic drugs to date, researchers at Johns Hopkins University and New York University have found that a single dose of psilocybinthe psychoactive compound in “magic” mushroomssubstantially diminished depression and anxiety in patients with advanced cancer.